Suppr超能文献

剑桥混合闭环应用与新型实时连续血糖监测系统的真实世界证据。

Real-World Evidence of the Cambridge Hybrid Closed-Loop App With a Novel Real-Time Continuous Glucose Monitoring System.

作者信息

Newman Christine, Hartnell Sara, Wilinska Malgorzata, Alwan Heba, Hovorka Roman

机构信息

Wolfson Diabetes and Endocrinology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

Wellcome-MRC Institute of Metabolic Science-Metabolic Research Laboratories, University of Cambridge, Cambridge, UK.

出版信息

J Diabetes Sci Technol. 2025 Jan;19(1):165-168. doi: 10.1177/19322968231187915. Epub 2023 Jul 28.

Abstract

We evaluated the performance of the interoperable Cambridge hybrid closed-loop app with FreeStyle Libre 3 glucose sensor, and YpsoPump insulin pump in a real-world setting. Data from 100 users (63 adults [mean ± SD age 41.9 ± 14.0 years], 15 children [8.6 ± 5.2 years)] and 22 users of unreported age) for a period of 28 days were analyzed. Time in range (3.91- 10.0mmol/L) was 72.6 ± 11.1% overall. Time below range (<3.9mmol/L) was 3.1% (1.4-5.1) (median [interquartile range]). Auto-mode was active for 95.8% (91.8-97.9) of time. This real-world analysis suggests that the performance of Cambridge hybrid closed-loop app with this glucose sensor is comparable to other commercially available hybrid closed-loop systems.

摘要

我们在实际环境中评估了可互操作的剑桥混合闭环应用程序与FreeStyle Libre 3葡萄糖传感器以及YpsoPump胰岛素泵的性能。分析了100名用户(63名成年人[平均±标准差年龄41.9±14.0岁]、15名儿童[8.6±5.2岁]以及22名未报告年龄的用户)在28天内的数据。总体而言,血糖处于目标范围(3.91-10.0mmol/L)的时间为72.6±11.1%。血糖低于目标范围(<3.9mmol/L)的时间为3.1%(1.4-5.1)(中位数[四分位间距])。自动模式开启时间占95.8%(91.8-97.9)。这项实际环境分析表明,该葡萄糖传感器搭配的剑桥混合闭环应用程序的性能与其他市售混合闭环系统相当。

相似文献

1
Real-World Evidence of the Cambridge Hybrid Closed-Loop App With a Novel Real-Time Continuous Glucose Monitoring System.
J Diabetes Sci Technol. 2025 Jan;19(1):165-168. doi: 10.1177/19322968231187915. Epub 2023 Jul 28.
2
Real-World Evidence Analysis of a Hybrid Closed-Loop System.
J Diabetes Sci Technol. 2025 Mar;19(2):385-389. doi: 10.1177/19322968231185348. Epub 2023 Jul 8.
7
One Year Clinical Experience of the First Commercial Hybrid Closed-Loop System.
Diabetes Care. 2019 Dec;42(12):2190-2196. doi: 10.2337/dc19-0855. Epub 2019 Sep 23.
10
Randomized Trial of Closed-Loop Control in Very Young Children with Type 1 Diabetes.
N Engl J Med. 2022 Jan 20;386(3):209-219. doi: 10.1056/NEJMoa2111673.

引用本文的文献

1
One-year evaluation of automated insulin delivery systems in adults with type 1 diabetes.
Front Digit Health. 2025 Jul 1;7:1596188. doi: 10.3389/fdgth.2025.1596188. eCollection 2025.
2
Real-World Evidence of Automated Insulin Delivery System Use.
Diabetes Technol Ther. 2024 Mar;26(S3):53-65. doi: 10.1089/dia.2023.0442.

本文引用的文献

2
One-year real-world performance of the DBLG1 closed-loop system: Data from 3706 adult users with type 1 diabetes in Germany.
Diabetes Obes Metab. 2023 Jun;25(6):1607-1613. doi: 10.1111/dom.15008. Epub 2023 Feb 21.
3
The Artificial Pancreas and Type 1 Diabetes.
J Clin Endocrinol Metab. 2023 Jun 16;108(7):1614-1623. doi: 10.1210/clinem/dgad068.
5
6. Glycemic Targets: Standards of Care in Diabetes-2023.
Diabetes Care. 2023 Jan 1;46(Suppl 1):S97-S110. doi: 10.2337/dc23-S006.
6
14. Children and Adolescents: Standards of Care in Diabetes-2023.
Diabetes Care. 2023 Jan 1;46(Suppl 1):S230-S253. doi: 10.2337/dc23-S014.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验